Correlation of coronary with peripheral arterial stenosis. The POSCH Group

J N Karnegis1, J P Matts, N Tuna

  • 1University of Nebraska, Omaha.

Atherosclerosis
|January 1, 1992
PubMed

Insights

Coronary artery disease does not always mean peripheral arterial disease is present. However, when peripheral arterial disease occurs, its severity correlates with coronary artery stenosis severity.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Peripheral arterial disease (PAD) is a known risk factor for coronary arterial stenosis.
  • The relationship between coronary artery disease (CAD) and peripheral arterial stenosis has not been extensively studied.

Purpose of the Study:

  • To investigate the correlation between coronary artery stenosis and peripheral arterial stenosis.
  • To determine if CAD predicts the presence or severity of peripheral arterial stenosis.

Main Methods:

  • Systematic analysis of coronary and aortic-iliac-femoral arteriograms.
  • Utilized data from the Program on Surgical Control of the Hyperlipidemias (POSCH) trial.
  • Included 436 hyperlipidemic subjects with a history of myocardial infarction and confirmed CAD.

Main Results:

  • 44% of subjects had normal aortic-iliac-femoral arteries.
  • Only 9% had less than 50% stenosis in all three major coronary arteries.
  • A significant positive correlation (P < 0.001) was found between the severity of stenosis in peripheral and coronary arteries.
  • Subjects with peripheral arterial disease were older and more likely to be smokers.

Conclusions:

  • Coronary artery stenosis does not invariably coexist with peripheral arterial stenosis.
  • The severity of peripheral arterial stenosis correlates with the severity of coronary artery stenosis.
  • A significant proportion of patients with coronary artery disease may not have significant peripheral arterial disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...